CAELUM BIOSCIENCES Trademark

Trademark Overview


On Thursday, January 12, 2017, a trademark application was filed for CAELUM BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the CAELUM BIOSCIENCES trademark a serial number of 87982774. The federal status of this trademark filing is REGISTERED as of Tuesday, April 21, 2020. This trademark is owned by Caelum Biosciences, Inc.. The CAELUM BIOSCIENCES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biochemical research and development; Biological research; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical research services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research services; Scientific research consulting in the field of amyloidosis and diseases where amyloid deposits are present; Scientific research consulting in the field of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, progressive organ disease and failure; Scientific research consulting in the field of serious and life threatening diseases; Scientific research for medical...
caelum biosciences

General Information


Serial Number87982774
Word MarkCAELUM BIOSCIENCES
Filing DateThursday, January 12, 2017
Status700 - REGISTERED
Status DateTuesday, April 21, 2020
Registration Number6037766
Registration DateTuesday, April 21, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 5, 2017

Trademark Statements


Disclaimer with Predetermined Text"BIOSCIENCES"
Goods and ServicesBiochemical research and development; Biological research; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical research services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research services; Scientific research consulting in the field of amyloidosis and diseases where amyloid deposits are present; Scientific research consulting in the field of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, progressive organ disease and failure; Scientific research consulting in the field of serious and life threatening diseases; Scientific research for medical purposes in the field of amyloidosis and diseases where amyloid deposits are present; Scientific research for medical purposes in the field of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, progressive organ disease and failure; Scientific research for medical purposes in the field of serious and life threatening diseases; Research in the field of pharmacogenetics; Conducting clinical trials for others in the field of pharmaceuticals; Research services in the field of proteins, antibodies, microorganisms and cells; Research and development services in the field of antibody technology; Structural and functional analysis of genomes; DNA screening for scientific research purposes; Biochemical research and analysis; research and development services in the field of immunology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 19, 2017
Primary Code042
First Use Anywhere DateSunday, January 1, 2017
First Use In Commerce DateSunday, January 1, 2017

Trademark Owner History


Party NameCaelum Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Party NameCaelum Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Party NameCaelum Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10014

Trademark Events


Event DateEvent Description
Thursday, April 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 26, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, October 26, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, October 26, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 26, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 21, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, March 17, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sunday, March 15, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 26, 2020STATEMENT OF USE PROCESSING COMPLETE
Monday, January 27, 2020USE AMENDMENT FILED
Wednesday, February 26, 2020DIVISIONAL PROCESSING COMPLETE
Monday, January 27, 2020DIVISIONAL REQUEST RECEIVED
Wednesday, February 26, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 27, 2020TEAS REQUEST TO DIVIDE RECEIVED
Monday, January 27, 2020TEAS STATEMENT OF USE RECEIVED
Thursday, June 27, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 25, 2019SOU EXTENSION 3 GRANTED
Tuesday, June 25, 2019SOU EXTENSION 3 FILED
Tuesday, June 25, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, January 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 7, 2019SOU EXTENSION 2 GRANTED
Monday, January 7, 2019SOU EXTENSION 2 FILED
Monday, January 7, 2019SOU TEAS EXTENSION RECEIVED
Saturday, July 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 19, 2018SOU EXTENSION 1 GRANTED
Thursday, July 19, 2018SOU EXTENSION 1 FILED
Thursday, July 19, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, January 30, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 5, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 26, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 25, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 24, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 24, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 28, 2017COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Friday, April 28, 2017ASSIGNED TO LIE
Friday, April 28, 2017NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, April 28, 2017EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Friday, April 28, 2017EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Thursday, April 6, 2017ASSIGNED TO EXAMINER
Thursday, January 19, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 16, 2017NEW APPLICATION ENTERED